Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • Guaranteed Paid Placement
  • SocialBoost
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Overview
  • Distribution by PR Newswire
  • AI Tools
  • Multichannel Amplification
  • SocialBoost
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Forum 30: Advancing Global Standards for Medical Products of Human Origin
  • India - English


News provided by

ICCBBA

Jan 22, 2025, 10:46 ET

Share this article

Share toX

Share this article

Share toX

Forum 30 Summit
Forum 30 Summit

REDLANDS, Calif., Jan. 22, 2025 /PRNewswire/ -- The International Council for Commonality in Blood Banking Automation ("ICCBBA"), in partnership with the Italian national competent authority for blood Centro Nazionale Sangue ("CNS") and for cells/tissues Centro Nazionale Trapianti ("CNT"), hosted Forum 30 The MPHO Safety and Traceability Summit on 14-15 November 2024. The event convened over 100 health professionals, patients, regulators, and other stakeholders from 34 countries around the world. They addressed critical challenges and opportunities concerning safety, and traceability of Medical Products of Human Origin (MPHO). Key discussions highlighted the importance of global cooperation to safeguard patients and foster innovation in the application of these therapies. Celebrating ICCBBA's 30th anniversary, the event reaffirmed the transformative role of the ISBT 128 Standard in ensuring the safety and traceability of MPHOs worldwide.

The event emphasized the life-saving and life-changing nature of MPHO, common characteristics of otherwise diverse therapeutic products and the importance of nurturing global cooperation in safeguarding patients receiving MPHO.

Discussions also emphasized technical interoperability to ensure safe management of MPHO and the need to address challenges through global regulatory alignment. Experience was shared of investigations of MPHO-related adverse events and how harm to recipients and healthcare professionals could be minimized.

The conference also celebrated the 30th anniversary of the founding of ICCBBA in 1995 and the continued evolution of the globally recognized ISBT 128 Standard, which provides unique coding and traceability standards for MPHOs.

Highlights and Action Steps

A diverse group of international experts presented on

  • The need for traceability to support MPHO safety and efficiency in their management
  • How technical innovation and informational interoperability supports safe access to MPHO
  • The need for global regulatory alignment to address evolving challenges in the therapeutic application of MPHO

Key announcements included the preparation by the World Health Organization (WHO) of a global strategy for MPHOs including regional consultations with member states. The goal is to present the strategy for adoption at the 2026 World Health Assembly.

Events like Forum 30 help strengthen international collaboration among standards development organizations, professional associations and governmental organizations to enhance implementation and global impact. Participants called for similar multi-stakeholder events like Forum 30 to be repeated at national or regional levels.

Executive Reflections

Eoin McGrath, ICCBBA Executive Director, emphasized the collaborative nature of the event: "The Forum 30 conference was designed to reflect the complex landscape of transplantation, with multiple stakeholders and actors all having a role to play. ICCBBA understands the importance of partnering with diverse organizations to advance safety and traceability of substances of human origin. Working with CNT and CNS was one of the success factors behind Forum 30 given their extensive experience and the high respect in which they are held by their peers in the European Union and further afield."

CNS Director Vincenzo De Angelis, remarked on the significance of robust regulatory standards: "The critical importance of robust regulatory standards and traceability in the management of MPHOs was underscored as a cornerstone of patient safety. With human-derived products playing an integral role in modern medicine, ensuring their safe collection, processing, and distribution through stringent protocols is essential for protecting both donors and recipients, while fostering trust in healthcare systems worldwide. We were deeply honored to host this event where global experts gathered to advance the standards that safeguard lives and drive innovation in this vital field."

CNT Director Giuseppe Feltrin highlighted Italy's leadership in transplantation: "It has been an honor for the National Transplant Centre to host this meeting. Italy plays a strategic role in the safety and oversight of organs, tissues, and cells as a WHO collaborating center for the Notify Project. Our National Transplant Information System is at the forefront of this field, thanks to the systematic implementation of international standards like the ISBT 128 Standard, which ensures globally unique identification of donations and a robust data structure to safeguard patients and guarantee care traceability. Our aim is to continue investing in safety and oversight to strengthen the global leadership of Italy's transplant network."

A Path Forward

Discussions highlighted the necessity to facilitate collaboration, advocacy, and standardization to ensure safe, and administration of MPHOs globally. Through its continued partnership with the WHO and other stakeholders, ICCBBA is committed to supporting advances in safety, and traceability through standards to improve patient safety and global health outcomes. Presentations from the event will be made available on the Forum 30 website.

About ICCBBA
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard.
The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the Standard. Today it expands as Information Standard for Blood and Transplantation. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set. The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation. ISBT 128 | ICCBBA

About CNS
The Italian national competent authority for blood and blood components acting as coordinator of the national system. Among others, it is responsible for regulatory blood inspectors' qualification through training activities. Homepage - Centro Nazionale Sangue

About CNT
The Italian national competent authority for organs, tissues, cells, and MAR coordinating activities from donation to transplantation. Among others, it is responsible for regulatory inspector's qualification through training activities. Trapianti (salute.gov.it)

 For the latest updates on the Forum 30 Summit
Subscribe to our ICCBBA newsletter at: https://www.isbt128.org/newsletter

For More Information
Forum 30 Homepage

Press Contact and other inquiries: 
Christina Salinas
Global Development Manager
ICCBBA
[email protected]

SOURCE ICCBBA

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

ICCBBA Expands Enterprise Grant Program: Total Funding Increased to $100,000 in 2025 to Enhance Global Patient Safety

ICCBBA Expands Enterprise Grant Program: Total Funding Increased to $100,000 in 2025 to Enhance Global Patient Safety

ICCBBA has released their annual Enterprise Grant. This year ICCBBA has increased the total fund to $100,000 USD. Each applicant can now request up...

ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety

ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety

ICCBBA is proud to announce the recipients of its 2024 Enterprise Grant Awards, recognizing three outstanding organizations that are advancing...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Licensing

Licensing

Trade Show News

Trade Show News

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.